Tallini LR, Osorio EH, Berkov S, Torras-Claveria L, Rodriguez-Escobar ML, Viladomat F, Meerow AW, Bastida J (2022) <br />Chemical Survey of Three Species of the Genus Rauhia Traub (Amaryllidaceae)<br /><i>Plants (Basel)</i> <b>11</b>: <br /><br />Crews FT, Fisher R, Deason C, Vetreno RP (2021) <br />Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine<br /><i>Front Behavioral Neuroscience</i> <b>15</b>: 652494<br /><br />Ka S, Masi M, Merindol N, Di Lecce R, Plourde MB, Seck M, Gorecki M, Pescitelli G, Desgagne-Penix I, Evidente A (2020) <br />Gigantelline, gigantellinine and gigancrinine, cherylline- and crinine-type alkaloids isolated from Crinum jagus with anti-acetylcholinesterase activity<br /><i>Phytochemistry</i> <b>175</b>: 112390<br /><br />Ortiz JE, Garro A, Pigni NB, Aguero MB, Roitman G, Slanis A, Enriz RD, Feresin GE, Bastida J, Tapia A (2018) <br />Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of Hieronymiella species<br /><i>Phytomedicine</i> <b>39</b>: 66<br /><br />Rocha REO, Lima LHF (2018) <br />Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study<br /><i>J Biomol Struct Dyn</i> <br /><br />Zhao J, Hylin MJ, Kobori N, Hood KN, Moore AN, Dash PK (2018) <br />Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome<br /><i>Journal of Neurotrauma</i> <b>35</b>: 362<br /><br />Cavallaro V, Alza NP, Murray MG, Murray AP (2014) <br />Alkaloids from Habranthus tubispathus and H. jamesonii, two amaryllidaceae with acetyl- and butyrylcholinesterase inhibition activity<br /><i>Nat Prod Commun</i> <b>9</b>: 159<br /><br />Berkov S, Viladomat F, Codina C, Suarez S, Ravelo A, Bastida J (2012) <br />GC-MS of amaryllidaceous galanthamine-type alkaloids<br /><i>J Mass Spectrom</i> <b>47</b>: 1065<br /><br />Berkov S, Bastida J, Nikolova M, Viladomat F, Codina C (2008) <br />Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts<br /><i>Phytochem Anal</i> <b>19</b>: 411<br /><br />Greenblatt HM, Guillou C, Guenard D, Argaman A, Botti SA, Badet B, Thal C, Silman I, Sussman JL (2004) <br />The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design<br /><i>Journal of the American Chemical Society</i> <b>126</b>: 15405<br /><br />Lopez S, Bastida J, Viladomat F, Codina C (2002) <br />Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts<br /><i>Life Sciences</i> <b>71</b>: 2521<br /><br />Bartolucci C, Perola E, Pilger C, Fels G, Lamba D (2001) <br />Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs<br /><i>Proteins</i> <b>42</b>: 182<br /><br />Guillou C, Mary A, Renko DZ, Gras E, Thal C (2000) <br />Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <b>10</b>: 637<br /><br />Bachus R, Bickel U, Thomsen T, Roots I, Kewitz H (1999) <br />The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6<br /><i>Pharmacogenetics</i> <b>9</b>: 661<br /><br />Davis KL (1999) <br />Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington<br /><i>Geriatrics</i> <b>54</b>: 42<br /><br />Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL (1999) <br />Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution<br /><i>FEBS Letters</i> <b>463</b>: 321<br /><br />Iliev A, Traykov V, Prodanov D, Mantchev G, Yakimova K, Krushkov I, Boyadjieva N (1999) <br />Effect of the acetylcholinesterase inhibitor galanthamine on learning and memory in prolonged alcohol intake rat model of acetylcholine deficit<br /><i>Methods Find Exp Clin Pharmacol</i> <b>21</b>: 297<br /><br />Pokorna L, Revilla A, Havel J, Patocka J (1999) <br />Capillary zone electrophoresis determination of galanthamine in biological fluids and pharmaceutical preparatives: experimental design and artificial neural network optimization<br /><i>Electrophoresis</i> <b>20</b>: 1993<br /><br />Giacobini E (1998) <br />Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications<br /><i>Neurochem Int</i> <b>32</b>: 413<br /><br />Mary A, Renko DZ, Guillou C, Thal C (1998) <br />Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series<br /><i>Bioorganic & Medicinal Chemistry</i> <b>6</b>: 1835<br /><br />Moraes-Cerdeira RM, Burandt CL, Jr., Bastos JK, Nanayakkara D, Mikell J, Thurn J, McChesney JD (1997) <br />Evaluation of four Narcissus cultivars as potential sources for galanthamine production [letter]<br /><i>Planta Med</i> <b>63</b>: 472<br /><br />Sharma A, Parikh V, Singh M (1997) <br />Pharmacological basis of drug therapy of Alzheimer's disease<br /><i>Indian J Exp Biol</i> <b>35</b>: 1146<br /><br />Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW, Jr., Davis L, Vargas HM (1996) <br />Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>277</b>: 728<br /><br />Fulton B, Benfield P (1996) <br />Galanthamine. [Review] [23 refs]<br /><i>Drugs & Aging</i> <b>9</b>: 60<br /><br />Prozorovskii VB, Velikova VD, Pshenkina NN, Vasilenko ET (1996) <br />[The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances]. [Russian]<br /><i>Eksperimentalnaia i Klinicheskaia Farmakologiia</i> <b>59</b>: 64<br /><br />Harvey AL (1995) <br />The pharmacology of galanthamine and its analogues<br /><i>Pharmacol Ther</i> <b>68</b>: 113<br /><br />Lewandowski MH, Zmuda L (1995) <br />Effect of the cholinesterase-inhibiting substance galanthamine on evoked visual potentials in rats<br /><i>Acta Neurobiologiae Experimentalis</i> <b>55</b>: 141<br /><br />Storch A, Schrattenholz A, Cooper JC, Abdel Ghani EM, Gutbrod O, Weber KH, Reinhardt S, Lobron C, Hermsen B, Soskic V, Pereira EF, Albuquerque EX, Methfessel C, Maelicke A (1995) <br />Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells<br /><i>European Journal of Pharmacology</i> <b>290</b>: 207<br /><br />Prozorovskii VB, Livanov GA, Velikova VD, Afanas'ev VV, Pavlova LV (1994) <br />[Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers]. [Russian]<br /><i>Eksperimentalnaia i Klinicheskaia Farmakologiia</i> <b>57</b>: 13<br /><br />Thomsen T, Kaden B, Fischer JP, Bickel U, Barz H, Gusztony G, Cervos-Navarro J, Kewitz H (1991) <br />Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine<br /><i>European Journal of Clinical Chemistry & Clinical Biochemistry</i> <b>29</b>: 487<br /><br />Kuznetsova LP, Kugusheva LI, Nikol'skaia EB (1990) <br />[Catalytic properties of cholinesterases immobilized in a gelatin membrane]<br /><i>Ukr Biokhim Zh</i> <b>62</b>: 42<br /><br />Thomsen T, Kewitz H (1990) <br />Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo<br /><i>Life Sciences</i> <b>46</b>: 1553<br /><br />Westra P, van Thiel MJ, Vermeer GA, Soeterbroek AM, Scaf AH, Claessens HA (1986) <br />Pharmacokinetics of galanthamine (a long-acting anticholinesterase drug) in anaesthetized patients<br /><i>British Journal of Anaesthesia</i> <b>58</b>: 1303<br /><br />Krivoi II, Kuleshov VI, Matiushkin DP, Sanotskii VI, Sei TP (1985) <br />[Miniature currents of the endplates of the muscle fibers of the diaphragm of the rat after inhibition of acetylcholinesterase with galanthamine]<br /><i>Neirofiziologiia</i> <b>17</b>: 607<br /><br />Vasilenko ET, Tonkopii VD (1974) <br />[Characteristics of galanthamine as a reversible inhibitor of cholinesterase]<br /><i>Biokhimiia</i> <b>39</b>: 701<br /><br />Kametani T, Yamaki K, Yagi H, Fukumoto K (1969) <br />Studies on the synthesis of heterocyclic compounds. CCCXV. Modified total synthesis of (plus or minus)-galanthamine through phenol oxidation<br /><i>J Chem Soc Perkin 1</i> <b>18</b>: 2602<br /><br />Uyeo S, Shirai H, Koshiro A, Yashiro T, Kagei K (1966) <br />Galanthamine chemistry. VII. Synthesis of analogues of galanthamine<br /><i>Chem Pharm Bull (Tokyo)</i> <b>14</b>: 1033<br /><br />Nesterenko LN (1965) <br />[Influence exerted by galanthamine on the acetylcholinesterase activity of various regions of the brain]<br /><i>Farmakologiia i Toksikologiia</i> <b>28</b>: 413<br /><br />